DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Romond EH, Jeong JH, Rastogi P, Swain SM, Geyer Jr. CE, Ewer MS. et al.
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
J Clin Oncol 2012;
30: 3792-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.